NDRG1 and prostate carcinoma: It has been shown that in breast and prostate cancer, NDRG1 mRNA is differentially expressed throughout the cell cycle, peaking at the G1 and G2-M phases, with lower expression in the S phase; however, the biphasic expression of NDRG1 mRNA is absent in tumor cells (20).